IPC Launches QR Code-Enabled Online ADR Reporting Platform to Boost Patient Safety
New Delhi: In a major push toward digital healthcare transparency and patient safety, the Indian Pharmacopoeia Commission (IPC) under the Ministry of Health and Family Welfare has unveiled a new QR code enabled Online Adverse Drug Reaction (ADR) Reporting Platform, revolutionizing the way patients, caregivers, and consumers can report side effects from medicines.
The initiative, developed by the National Coordination Centre Pharmacovigilance Programme of India (NCC-PvPI), empowers individuals to instantly report suspected ADRs by simply scanning a QR code through their smartphones—anytime, anywhere.
The platform ensures real-time data capture, strengthening India’s pharmacovigilance framework and reinforcing its commitment to patient-centric and technology-driven healthcare oversight.
“We believe this initiative will simplify ADR reporting, allowing patients/caregivers and consumers to directly report suspected ADRs by scanning a QR code with their smartphones—anytime, anywhere. The streamlined digital interface ensures faster, more efficient reporting, reinforcing real-time surveillance and patient-centric pharmacovigilance,” an IPC official said.
The poster also highlights the PvPI Toll-Free Number (1800-180-3024), offering patients multiple avenues to report suspected drug reactions, further promoting awareness and proactive participation in drug safety monitoring.
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.